Eversept Partners’s Insmed INSM Stock Holding History

Eversept Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,089,404	Closed	-$79.5M	–	72
2024 Q3	$79.5M	Sell	1,089,404 -66,184	-6%	-$4.88M	5.45%	5
2024 Q2	$77.4M	Buy	+1,155,588	New	+$44.8M	5.3%	4

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Eversept Partners's INSM Position: Q4 2024 in Review

Eversept Partners sold out of Insmed (INSM) in Q4 2024, closing a stake of 1,089,404 shares — an estimated $79.5M sold.

Eversept Partners first reported a position in INSM in Q2 2024 and held it in 2 quarters. The position peaked at $79.5M in Q3 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

Eversept Partners reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
Eversept Partners sold 1,089,404 Insmed shares in Q4 2024, an estimated $79.5M.
Eversept Partners first reported a position in Insmed in Q2 2024 and held it in 2 quarters.
Eversept Partners's Insmed position peaked at $79.5M in Q3 2024.
438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Eversept Partners's 13F filing for Q4 2024, filed 14 Feb 2025.